Primary Category:
Treatment Protocols
Disease Category:
Lymphoma, Non-Hodgkin Lymphoma
Status:
Open
A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas
NCT#04803201
A051902 is open to accrual to the Randomized Phase II Safety check portion of the study, effective September 18. 2023.
